Clinical & Translation Session 10: Debate 2: The Role of CMR in HFpEF: Clinical Game-Changer or Overstated Promise?

Moderator(s)

• 

  Attila Feher, MD, PhD

  Assistant Professor of Medicine
  Department of Medicine, Section of Cardiovascular Medicine
  Yale University
  NEW HAVEN, Connecticut, United States
• 

  Ibraim Masciarelli Pinto, MD, PhD

  Director, Non Invasive Cardiology
  Instituto Dante Pazzanese de Cardiologia
  Sao Paulo, Sao Paulo, Brazil

Presentations:

• 11:10 AM - 11:25 AM  

  Pro position: How CMR Unlocks the Complexity of HFpEF
  

  Speaker: Daniel C. Lee, MD – Northwestern University Feinberg School of Medicine
• 11:25 AM - 11:40 AM  

  Con position: Why CMR Isn’t the Answer for HFpEF
  

  Speaker: Nadine Abanador-Kamper, MD, FSCMR – Helios University Hospital Wuppertal
• 11:40 AM - 11:45 AM  

  Pro rebbutal
  

  Speaker: Daniel C. Lee, MD – Northwestern University Feinberg School of Medicine
• 11:45 AM - 11:50 AM  

  Con rebbutal
  

  Speaker: Nadine Abanador-Kamper, MD, FSCMR – Helios University Hospital Wuppertal
• 11:50 AM - 12:10 PM  

  Discussion
  

  Panelist: Thor Edvardsen, MD, FESC – Oslo University Hospital

  Panelist: Ritu Thamman, MD FACC FASE – University of Pittsburgh School of Medicine